Combination anti-CXCR4 and anti-PD-1 immunotherapy provides survival benefit in glioblastoma through immune cell modulation of tumor microenvironment

Adela Wu, Russell Maxwell, Yuanxuan Xia, Pina Cardarelli, Miho Oyasu, Zineb Belcaid, Eileen Kim, Alice Hung, Andrew S. Luksik, Tomas Garzon-Muvdi, Christopher M. Jackson, Dimitrios Mathios, Debebe Theodros, John Cogswell, Henry Brem, Drew M. Pardoll, Michael Lim

Research output: Contribution to journalArticlepeer-review

60 Scopus citations

Fingerprint

Dive into the research topics of 'Combination anti-CXCR4 and anti-PD-1 immunotherapy provides survival benefit in glioblastoma through immune cell modulation of tumor microenvironment'. Together they form a unique fingerprint.

Medicine & Life Sciences